 |
We work with our clients to deliver contract research and consultancy services that are tailored to their individual requirements in terms of science, timelines and cost.
Our services
We employ state-of-the-art technologies and approaches and ensure our services
- are delivered by leading researchers in the field,
- are provided in world-class scientific facilities,
- are extremely competitively-priced, and,
- are associated with a high level of quality assurance
Atuka provides services in three broad categories
Assessment of pre-clinical efficacy - services to assess the ability of novel therapeutics to alleviate parkinsonian symptoms, reduce side effects of current therapies and to modify neurodegenerative processes. Atuka assesses therapeutic potential in vitro in dopaminergic cell lines and brain slices and in a wide range of rodent and non-human primate models of Parkinson's disease.
Assessment of clinical efficacy - services to design, conduct and interpret Phase II clinical trials for movement disorders. Atuka can provide such services within the context of world leading academic movement disorder units.
Consultancy services - provided by world leaders in the field of pre-clinical and clinical pharmacology provide high value support to pre-clinical and clinical development programmes and the financial community. We aid design of programmes for drug development, interpretation of key studies, evaluation of intellectual property and analysis of market or investment opportunities.
|
|
